New chemo approach aims to stop lymphoma from spreading to the brain
NCT ID NCT05257018
Summary
This study is testing whether adding a spinal fluid injection of methotrexate to a standard lymphoma chemotherapy regimen can prevent cancer from spreading to the brain and spinal cord in high-risk patients. The trial will enroll 83 adults with newly diagnosed diffuse large B-cell lymphoma who have features that make brain relapse more likely. Researchers will track whether this combined approach reduces brain relapse rates over two years while monitoring safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Cancer Hospital affilicaited to Xinjiang Medical University
NOT_YET_RECRUITINGÜrümqi, Xinjiang, China
Contact
Contact
-
Dongmei Ji
RECRUITINGShanghai, Shanghai Municipality, 021, China
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.